Long-Acting Risperidone Dual Control System: Preparation, Characterization and Evaluation In Vitro and In Vivo
Schizophrenia, a psychiatric disorder, requires long-term treatment; however, large fluctuations in blood drug concentration increase the risk of adverse reactions. We prepared a long-term risperidone (RIS) implantation system that can stabilize RIS release and established in-vitro and in-vivo evalu...
Main Authors: | Xieguo Yan, Shiqiang Wang, Kaoxiang Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/8/1210 |
Similar Items
-
Preparation of Alginate Microspheres for the Delivery of Risperidone
by: Al-Tahami K.
Published: (2014-12-01) -
Photostability of Risperidone in Tablets
by: Yuki Fujisawa, et al.
Published: (2017-06-01) -
Risperidone oral disintegrating mini-tablets: A robust-product for pediatrics
by: El-Say Khalid M., et al.
Published: (2015-12-01) -
Risperidone Controlled Release Microspheres Based on Poly(Lactic Acid)-Poly(Propylene Adipate) Novel Polymer Blends Appropriate for Long Acting Injectable Formulations
by: Stavroula Nanaki, et al.
Published: (2018-08-01) -
Effects of Continuing Oral Risperidone vs. Switching from Risperidone to Risperidone Long-Acting Injection on Cognitive Function in Stable Schizophrenia Patients: A Pilot Study
by: Hikaru Hori, et al.
Published: (2018-03-01)